ZETA SURGICAL · Jul 2026
The company announced FDA 510(k) clearance for its robotic TMS system, which dynamically tracks patient movement and adjusts coil positioning with sub-millimeter-level accuracy.
Next-Generation Surgical Navigation and Robotics
Public company, workplace, funding, and market signals
Updated Aug 2, 2026
ZETA SURGICAL (formerly Z Imaging) is a Boston-based private medical-device and digital-surgery company founded in 2018. It develops frameless, AI-powered neuronavigation and robotic platforms intended to bring precise image guidance beyond the traditional operating room, including ambulatory, emergency, interventional, and mental-health settings.
Primary product
The Zeta platform: the FDA-cleared Zeta Navigation System with Zeta Stylet and Zeta Bolt for image-guided neurosurgical procedures, plus the Zeta TMS Navigation/Robotic System for precision-guided transcranial magnetic stimulation.
Founded
2018
Headquarters
Boston, Massachusetts, United States
Team size
1–10 publicly reported; YC lists team size 12
Industry
Medical equipment manufacturing
Sub-industry
Neurosurgical navigation, medical robotics, digital surgery, and neuromodulation
24 jobs at ZETA SURGICAL
Offices
Business model
Stage
Seed / early commercial-stage private company
Total raised
$8.5M
Latest round
Seed VC - IV · Nov 2023
Latest amount
$1.1M
Jan 2025
Nov 2023 · Innospark Ventures
Nov 2023
Mar 2022
Mar 2022 · Innospark Ventures
Mar 2022
Jan 2022
Seed / YC and Plug and Play pre-seed
Aug 2019 · Y Combinator / Plug and Play Tech Center
May 2017 · MassChallenge
Leadership
Co-Founder and CEO
Co-Founder and CTO
William Gormley
Co-Founder and Chief Medical Officer
Chief Operating Officer; Director of Operations
Chief Product Officer
Chief Business Officer and General Counsel
Matthew McGirt
Chief Strategy Officer
Investors
The company describes itself as a multidisciplinary team of engineers, scientists, designers, operators, and clinicians. Public hiring material emphasizes mission-driven work, rapid product development, clinical collaboration, and improving surgical accuracy, safety, and accessibility.
Compensation
A public Operations Associate listing showed $50,000–$85,000. Public internship listings indicated paid stipends, with third-party reposts showing approximately $3,500–$5,000 for a listed internship period. H-1B labor-condition data reports two filings since FY2022, including one FY2025 filing at $150,000 and one FY2022 filing at $85,000; this is not proof of a general sponsorship policy.
Benefits
Pricing
Not publicly disclosed; appears to be enterprise medical-device deployment and/or sale plus procedure-specific instruments/accessories.
Differentiators
Technology
Customers
Competitors
Estimated revenue
Approximately $1M–$10M; third-party estimates range from about $2M to $4.3M annually and should be treated as directional, not audited.
Estimated monthly visits
2.7K
Traffic estimate as of Aug 2026
ZETA SURGICAL · Jul 2026
The company announced FDA 510(k) clearance for its robotic TMS system, which dynamically tracks patient movement and adjusts coil positioning with sub-millimeter-level accuracy.
Investing News Network / PR Newswire · Jun 2026
Partnership/commercial milestone: first patient treatment using the Zeta TMS Navigation System at a HOPE Therapeutics clinic in Sarasota; HOPE had installed systems in Sarasota and West Palm Beach.
ZETA SURGICAL · Jun 2026
The companies announced the first patient treatment with the FDA-cleared Zeta TMS Navigation System at a HOPE Therapeutics clinic in Sarasota.
Zeta Surgical / PR Newswire · May 2026
Regulatory milestone: FDA clearance for the Zeta Navigation System, Zeta Stylet and Zeta Bolt; company said it planned a commercial pilot with the Big 10 Neurosurgical Consortium.
PR Newswire / ZETA SURGICAL · May 2026
FDA cleared the Zeta Navigation System together with the Zeta Stylet and Zeta Bolt for several neurosurgical applications; the company cited a 15-patient first-in-human ventriculostomy study and a planned large commercial pilot.